The company is expanding its digital health platform into new treatment areas, specifically low testosterone and menopause care. This strategic move broadens its service scope and potential customer base. Furthermore, management has outlined ambitious future growth plans, targeting the longevity market and initiating global expansion efforts set for 2026. This evolution of its service offerings positions the company to capitalize on significant, underserved healthcare segments and drive future revenue streams.